APPLICATION
ANDA075843
TYPE
ANDA
ORIGINAL APPROVAL
2001-10-03
LATEST ACTION
2003-04-18
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
OXAPROZINDiscontinued
OXAPROZIN 600MG · TABLET · ORAL
Approval history
2003-04-18Labeling · Supplement 3AP
2002-03-13Manufacturing (CMC) · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.